Form 4: Rosalind Advisors Acquires 400,000 Common Shares of Delcath Systems Through Warrant Exercise

Rosalind Advisors, along with related individuals, reports acquisition of 400,000 common shares of Delcath Systems through warrant exercise, impacting their beneficial ownership.

Summary

• Rosalind Advisors, Inc., Steven Salamon, and Gil Aharon, all directors and 10% owners of Delcath Systems, Inc., filed a Form 4.
• The filing reports a transaction on May 5, 2025, where Rosalind Opportunities Fund I L.P. exercised warrants to acquire 400,000 common shares at $10 per share.
• Following the transaction, Rosalind Advisors Inc., as advisor to the Rosalind Funds, indirectly beneficially owns 3,413,468 shares.
• This includes shares held by Rosalind Master Fund L.P. (1,565,844), Rosalind Opportunities Fund I L.P. (1,734,545), Steven Salamon (82,197), and Gilad Aharon (30,882).

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a standard transaction (warrant exercise) by a significant shareholder. The exercise of warrants at $10 could be seen as a positive signal, but the document itself is purely informational.

Positives

• The exercise of warrants demonstrates confidence in Delcath Systems by Rosalind Opportunities Fund I L.P.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence due to the warrant exercise.

Key Dates

Keywords

Delcath Systems, Rosalind Advisors, Form 4, Beneficial Ownership, Warrant Exercise, Common Shares, Directors, 10% Owner